Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06543407 · ClinicalTrials.gov registry record · NA
Harm Reduction for Smokers With Mental Illness
A NA study of Tobacco Dependence, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT06543407: Recruiting NA study of Tobacco Dependence, sponsored by Dartmouth-Hitchcock Medical Center.
NCT06543407 is a NA study of Tobacco Dependence that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 250 participants, below the 470-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (47% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06543407, a NA study of Tobacco Dependence, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
To compare the efficacy of e-cigarette (e-cig) provision with or without behavioral support (SWITCH IT) delivered via telehealth to reduce harm among smokers with MI who cannot quit smoking and are not ready to pursue cessation treatment, and to examine self-regulation (using e-cigs instead of cigarettes to cope with stress/distress and self-efficacy) as a potential mechanism for behavior change from SWITCH IT
Primary Outcome
urine levels of NNAL
Conditions Studied
Interventions
- BEHAVIORAL SWITCH IT
- OTHER E-cig Provision Only
Study Locations (2)
Kentucky
- Seven Counties Services - Louisville
Rhode Island
- The Providence Center - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06543407 shows while recruiting
NCT06543407 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 470-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 2 interventions - of which SWITCH IT is the first listed.
NCT06543407 reports a single indexed study location in Kentucky, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06543407 about?
NCT06543407 is a clinical study titled "Harm Reduction for Smokers With Mental Illness". To compare the efficacy of e-cigarette (e-cig) provision with or without behavioral support (SWITCH IT) delivered via telehealth to reduce harm among smokers with MI who cannot quit smoking and are not ready to pursue cessation treatment, and to examine self-regulation (using e-cigs instead of cigar...
What is the current status of trial NCT06543407?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-10-01. Estimated completion is 2028-03-31.
What conditions does trial NCT06543407 study?
This clinical trial studies the following conditions: Tobacco Dependence.
What interventions are being tested in trial NCT06543407?
The interventions under investigation include: SWITCH IT (BEHAVIORAL), E-cig Provision Only (OTHER).
Who is sponsoring clinical trial NCT06543407?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06543407 being conducted?
This trial has 2 study locations across Kentucky, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06543407's enrollment target sits among peer trials
250 14th of 28 higher than 15 of 28 other Tobacco Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
RECRUITING · NA
-
Use of Nicotine Pouches Among Daily Smokers
RECRUITING · NA
-
Smoke-free Home Study in Subsidized Housing
RECRUITING · NA
-
Assessment of Biomarkers in Children to Help Parents Quit Tobacco
ACTIVE NOT RECRUITING · NA
-
Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI